Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB03002 versus daily Genotropin in treatment-naive children with growth hormone deficiency
2005-000346-36Phase 3Completed
- Sponsor
- BioPartners
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in growth hormone deficiency (GHD) comparing LB03002 with Daily Genotropin (2 arms). Primary endpoint: Height velocity at 12 months. Started May 2005; status: completed.
02
Drugs
Eutropin Plussomatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2005-000346-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000346-36.